Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Xerostomia - Overview
Xerostomia - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Xerostomia - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Xerostomia - Companies Involved in Therapeutics Development
BioCurity Pharmaceuticals Inc
Capricor Therapeutics Inc
Humanetics Corp
Icure Pharmaceutical Inc
Lubris Biopharma
MeiraGTx Holdings Plc
MyX Therapeutics Inc
Xerostomia - Drug Profiles
A-00X - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CAP-2003 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
cerium oxide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drug for Xerostomia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drugs for Enteritis, Proctitis, Pulmory Inflammation, Radiodermatitis, and Xerostomia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
genistein - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
LBS-020 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pilocarpine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Xerostomia - Dormant Projects
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Xerostomia, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products by Targets, H2 2019
Number of Products by Stage and Targets, H2 2019
Number of Products by Mechanism of Actions, H2 2019
Number of Products by Stage and Mechanism of Actions, H2 2019
Number of Products by Routes of Administration, H2 2019
Number of Products by Stage and Routes of Administration, H2 2019
Number of Products by Molecule Types, H2 2019
Number of Products by Stage and Molecule Types, H2 2019


List of Tables


Number of Products under Development for Xerostomia, H2 2019
Number of Products under Development by Companies, H2 2019
Products under Development by Companies, H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Xerostomia - Pipeline by BioCurity Pharmaceuticals Inc, H2 2019
Xerostomia - Pipeline by Capricor Therapeutics Inc, H2 2019
Xerostomia - Pipeline by Humanetics Corp, H2 2019
Xerostomia - Pipeline by Icure Pharmaceutical Inc, H2 2019
Xerostomia - Pipeline by Lubris Biopharma, H2 2019
Xerostomia - Pipeline by MeiraGTx Holdings Plc, H2 2019
Xerostomia - Pipeline by MyX Therapeutics Inc, H2 2019
Xerostomia - Dormant Projects, H2 2019